T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis2023-07-202023-07-20/wp-content/uploads/2022/02/canopy-logo-2022-white.pngCanopy Biosciences/wp-content/uploads/2022/02/canopy-logo-2022-white.png200px200px